The role serves as a critical interface between regional Medical Affairs teams and global R&D, Global Product Development and Commercialization functions, partnering closely with US and EUR/INT colleagues to ensure regional insights and priorities are understood, communicated, and appropriately considered within the Clinical Development Team (CDT), Late Development Team (LDT), Medical Functional Matrix Team (mFMT), and governance forums including the Product Governance Committee (PGC) and Development Project Review Committee (DPRC). Success in this role requires strong partnership with regional teams, particularly in the US, to maintain close alignment with regional medical strategies and ensure that evidence generation activities and development plans address the needs of physicians, patients, and healthcare systems across regions.